Jae-Hong Lee

Professor

Asan Medical Center

South Korea

Research Interests

Explore related searches

Professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jae-Hong Lee is a Professor at Asan Medical Center in South Korea. His research primarily focuses on Alzheimer's disease, particularly the incidence and imaging characteristics of amyloid-related abnormalities in patients undergoing anti-amyloid therapies. He has also contributed to studies on the impacts of treatments on language dysfunction and neuroimaging in dementia. His recent publications reflect a keen interest in advancing knowledge regarding amyloid imaging and its implications for clinical practice.

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (8)

Young Chul Youn

Professor

Chungbuk National University Hospital

SOUTH KOREA

View details

Cynthia Lemere

Professor of Neurology

Brigham and Women's Hospital and Harvard Medical School

UNITED STATES

View details

Jae-Sung Lim

Clinical Associate Professor

Asan Medical Center

SOUTH KOREA

View details

Young-Soon Yang

Soonchunhyang University College of Medicine

SOUTH KOREA

View details

Jae Seung Kim

University of Ulsan College of Medicine

SOUTH KOREA

View details

Jee Hoon Roh

Professor (Adjunct)

Seoul National University Hospital

SOUTH KOREA

View details

Seong-Ho Koh

Professor

Hanyang University

SOUTH KOREA

View details

Jungsu Oh

Professor

Asan Medical Center, University of Ulsan College of Medicine

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jae-Hong Lee

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Incidence of Amyloid-Related Imaging Abnormalities in Phase III Clinical Trials of Anti-Amyloid-β Immunotherapy

Anti-Amyloid Imaging Abnormality in the Era of Anti-Amyloid Beta Monoclonal Antibodies: Recent Updates for the Radiologist

Amyloid-Related Imaging Abnormalities in the Era of Anti-Amyloid Beta Monoclonal Antibodies for Alzheimer’s Disease: Recent Updates on Clinical and Imaging Features and MRI Monitoring

Effects of GV1001 on Language Dysfunction in Patients With Moderate-to-Severe Alzheimer’s Disease: Post Hoc Analysis of Severe Impairment Battery Subscales

Teaching NeuroImage: Glucose Hypermetabolism in the Basal Ganglia

[18F]THK-5351 PET Patterns in Patients With Alzheimer’s Disease and Negative Amyloid PET Findings

Incidence of Amyloid-Related Imaging Abnormalities in Patients With Alzheimer Disease Treated With Anti–β-Amyloid Immunotherapy

Cilostazol Versus Aspirin on White Matter Changes in Cerebral Small Vessel Disease: A Randomized Controlled Trial

An Autopsy-Proven Case of Lewy Body Disease Presenting with Severe Dysphagia

False Memory and Alzheimer’s Disease Pathology in Patients with Amnestic Mild Cognitive Impairment: A Study with Amyloid PET

The cerebellum could serve as a potential imaging biomarker of dementia conversion in patients with amyloid‐negative amnestic mild cognitive impairment

Quantitative and Qualitative Differences of Action Verbal Fluency between Young and Older Adults

Development and Validation of a Deep Learning–Based Automatic Brain Segmentation and Classification Algorithm for Alzheimer Disease Using 3D T1-Weighted Volumetric Images

Collaborators (8)

Young Chul Youn

Cynthia Lemere

Jae-Sung Lim

Young-Soon Yang

Jae Seung Kim

Jee Hoon Roh

Seong-Ho Koh

Jungsu Oh

Make your next move.